Ravi Shah
Clinical Cardiac Electrophysiology · Charlotte, NCNPI 1114305398
Payments from drug & device makers
What this record shows
This record is dominated by grants: $29,667 of the $39,832 with a category attached, or 74.5%. 10 manufacturers reported payments, led by Boston Scientific at 34.5% of the total. Reporting peaked in 2023 at $18,048 and has fallen 72.8% since, to $4,913 in 2025.
Across 70 payments — averaging $569.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$14K
- Abbott$14K
- Medtronic$10K
- Altathera Pharmaceuticals LLC$2K
- Biosense Webster, Inc.$144
- Biotronik Inc.$92
- plus $142 from 4 others
What the payments were for
- Consulting fees$1,5004%
- Grants$29,66774%
- Travel & lodging$5,26513%
- Food & beverage$2,7807%
- Education$6212%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 25 | $13,735 |
| Abbott | 29 | $13,579 |
| Medtronic | 6 | $9,872 |
| Altathera Pharmaceuticals LLC | 3 | $2,268 |
| Biosense Webster, Inc. | 1 | $144 |
| Biotronik Inc. | 2 | $92 |
| Glaukos Corporation | 1 | $64 |
| Abiomed | 1 | $30 |
| AbbVie | 1 | $30 |
| Cardiva Medical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBLEM MRI S-ICD$5,851
- GENERAL - THERAPIES$2,357
- Sotalol Hydrochloride$2,268
- ENSITE PRECISION$1,563
- AVEIR$1,188
- EnSite Precision Cardiac Mapping System$209
- AURORA EV-ICD MRI SURESCAN$169
- Ensite Cardiac Mapping System$152
- Carto 3$144
How this compares
$39,832 in reported general payments places this provider in the 60th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.
See all clinical cardiac electrophysiology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 25 | $27,340 |
| Amiodarone Hcl | 27 | $1,711 |
| Metoprolol Succinate | 31 | $452 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Charlotte
- Shana GreifCharlotte$33K
- Thomas KamburCharlotte$29K
- Joseph ThompsonCharlotte$15K
- Kevin HsuCharlotte$14K
- Michael ManogueAsheville$230K
- Daniel FriedmanDurham$196K
- James AllredGreensboro$184K
- John RhynerAsheville$168K
- Gregory HarrisGreenville$164K
- John CatanzaroGreenville$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.